Catharanthine Market

Catharanthine Market Size by Type (Catharanthine sulphate, and Catharanthine tartrate), By Application (Pharmaceutical, Food and Beverages, and Others), Global Industry Analysis, Share, Growth, Trends, and Forecast 2022 to 2030

Base Year: 2021 Historical Data: 2019-20
  • Report ID: TBI-13075
  • Published Date: Nov, 2022
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The catharanthine market was estimated at around USD 746.5 million in 2021, growing at a CAGR of nearly 4.2% during 2022-2030. The market is projected to reach approximately USD 1,087 million by 2030.

Catharanthine Market: Overview

Chemicals made from petroleum are known as catharanthine. Products made from catharanthine Catharanthus roseus, a potent therapeutic plant for numerous pharmacological reactions like antibacterial, antioxidant, and antidiabetic impact, among others, contains an alkaloid known as catharanthine, which is an isolated from this plant. Vinblastine and vincristine, two anti-tumor medications, can be made from the fundamental molecule as a starting point. Both the widespread degranulation of pancreatic acinar cells and the stimulation of amylase release from pancreatic fragments are caused by it. Catharanthine has a variety of uses in the medical and pharmaceutical fields. It plays a significant role in the management of childhood cancer. Catharanthine is less well-known on the catharanthine market and, as a result, is still in its infancy. As a result, it has great potential going forward. The world market for catharanthine is tiny because it is a relatively new product. The catharanthine market is anticipated to expand quickly over the course of the forecast period as market players become more aware of the benefits of the compound.

The need for catharanthine-based medicines is rising as the number of people with chronic diseases including cancer and tumors rises. Throughout the projected period, the government's initiatives and a wide range of policies are anticipated to hasten the catharanthine market's expansion.

Catharanthine Market Size

Get an overview of this study by requesting a free sample

Catharanthine Market: COVID – 19 Impact Analysis

The COVID-19 pandemic had a significant impact on the pharmaceutical industry. The majority of raw material manufacturing facilities were closed, which reduced the production of catharanthine, and the drugs made from it. The supply chain was hampered by the nationwide lockdown and cross-border import/export restrictions. Because OEMs have been forced to operate at zero or partial capacity as a result of raw material delays or non-arrival, disrupted financial flows, and growing absenteeism among production line employees, there was less demand for and consumption of catharanthine in 2019–2020. The demand for catharanthine will increase and restore the market with only a slight economic interruption during the predicted period due to the burden of cancer incidence and mortality, which are both increasing quickly globally.

Catharanthine Market: Growth Drivers

Increasing cancer patients to accelerate the market’s growth

People of diverse racial backgrounds, sexual orientations, and socioeconomic statuses are affected by cancer. Cancer preventive and treatment methods have advanced over time, yet the number of cancer diagnoses seems to be increasing. Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study, 2019 and a study published in JAMA Oncology, 8.29 million persons worldwide died from cancer in 2010, with 18.7 million receiving a cancer diagnosis. In 2019, the figures had dramatically increased, with 23.6 million people receiving a new cancer diagnosis and data showing 10 million cancer deaths. According to the latest predictions from the IARC (International Agency for Cancer and Research), the number of 10.3 million cancer deaths and 19.3 million new cases of cancer worldwide in 2020. The National Cancer Institute estimates that in the United States, 1,806,590 new instances of cancer were diagnosed, and 606,520 people passed away from the condition. As of January 2019, there were 16.9 million cancer survivors in the US, according to reports. There will likely be 22.2 million cancer survivors by the year 2030. At some point throughout their lifetime, about 39.5% of men and women will receive a cancer diagnosis. The expected national cost of cancer care in 2020 was estimated to be USD 208.9 billion, an increase of 10% from the previous year's expense that can only be attributed to the ageing and population expansion of the United States. The market will expand throughout the anticipated period because catharanthine is used as a medicine for cancer condition.

Global healthcare spending is increasing per person

In 2019, per capita health spending in the United States exceeded USD 10,000, more than twice as much as in Australia, France, Canada, New Zealand, and the United Kingdom, according to OECD health data. At USD 4,092 per capita, U.S. private spending on health insurance premiums is the most of any nation. It is more than five times greater than Canada, which is the second-biggest spender. Private expenditures in Sweden and Norway totaled less than $100 per person. Private expenditure is substantially higher in the United States (40%) than it is in any other nation (0.3%–15%) as a percentage of overall spending. The typical American spends USD 1,122 out of pocket for healthcare. Less than half of what Americans spend is paid by citizens of France and New Zealand. Therefore, the Catharanthine Market will grow during the forecast period due to the rising per capita healthcare spending.

Catharanthine Market: Segmentation Analysis

The catharanthine market is segmented into the type, and application. Based on type, the market for catharanthine sulphate segment is estimated to lead the market during the forecast period. An anticancer alkaloid precursor of the vinblastine class is catharanthine sulphate. It functions by desensitizing the AChR and inhibiting ion channels (Acetylcholine Receptor). It is a natural alkaloid that prevents microtubule structures from forming, leading to cell death.

By application, the pharmaceutical segment is anticipated to dominant the catharanthine market during the forecast period. The two most significant indole alkaloids, vinblastine and vincristine, are therapeutically effective anticancer medications. Leukemias, lymphomas, and testicular cancer are all treated with vinblastine by systemic administration. KS has been treated with vinblastine given intravenously. It is a key component in the therapy of breast cancer and is also used to treat non-Hodgkin lymphoma. Vincristine is one of the most widely used pediatric chemotherapeutic drugs and is used to treat both solid tumors and hematologic malignancies. Hence, the rising patient of cancer is expected to drive the overall market during the forecast period.

Report Scope

Attribute Description
Base Year 2021
Forecast period 2022-2030
Report Coverage Revenue estimation and forecast, company profile, competitive landscape, growth factors, and recent trends
Regional scope North America, Europe, Asia Pacific, Middle East & Africa, and Latin America
Market Size(unit) USD Million
Catharanthine Market CAGR 4.2%
Segments Covered

By Type
By Application

Key Insights:

  • Based on type segmentation, the catharanthine sulphate segment is estimated to hold the largest market share during the forecast period.
  • Based on application segmentation, the pharmaceutical segment is the leading revenue-generating category during the forecast period.
  • On the basis of geography/region, the North America region was the leading revenue generator in 2021.

Recent Development

  • March 2022: To combat difficult cancers, Pepper Bio and the Stanford laboratory have teamed up. Utilizing its transomics technology, the drug development company will collaborate with the Dean Felsher Laboratory to find treatments for cancers that are now incurable.
  • June 2021: A three-year research agreement between Stanford University and the multinational specialty chemicals company Evonik is expected to result in a new polymer-based delivery system for mRNA that will outperform lipid nanoparticle (LNP) systems, which Evonik also manufactures. The contract grants the business the right to license and market the technology.

Regional Landscape

Throughout the projection period, North America is anticipated to remain one of the most alluring markets, accounting for the majority revenue share in the market. This is because the number of people with chronic diseases like cancer and tumors is increasing in the area. The pharmaceutical market has grown dramatically on a global scale, according to Internal Journal of Environmental Research and Public Health. The market was worth approximately USD 1.25 trillion in 2019.

List of the prominent players in the Global Catharanthine market:

  • AK Scientific Inc
  • Hainan Yueyang Biotech Co Ltd
  • Abcam
  • ChemFaces
  • Stanford Chemicals
  • Cayman Chemicals
  • Bio Vision Inc
  • Enzo Biochem Inc

The global Catharanthine market is segmented as follows:

By Type

  • Catharanthine sulphate
  • Catharanthine tartrate

By Application

  • Pharmaceutical
  • Food and Beverages
  • Others

By Region/Geography

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
  • Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Type
          4.3.2. Market Attractiveness Analysis By Application
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing cancer patients to accelerate the market’s growth
          5.2.2. Global healthcare spending is increasing per person
    5.3. Restrains
          5.3.1. High making cost of catharanthine would hamper the market
    5.4. Opportunities
          5.4.1. Growing patients and need of this product

6. Global Catharanthine Market Analysis and Forecast, By Type
    6.1. Segment Overview
    6.2. Catharanthine sulphate
    6.3. Catharanthine tartrate

7. Global Catharanthine Market Analysis and Forecast, By Application
    7.1. Segment Overview
    7.2. Pharmaceutical
    7.3. Food and Beverages
    7.4. Others

8. Global Catharanthine Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
          8.3.6. Rest of Europe
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
          8.4.4. Australia
          8.4.5. South Korea
          8.4.6. Rest of Asia-Pacific
    8.5. South America
          8.5.1. Brazil
          8.5.2. Argentina
          8.5.3. Rest of South America
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa
          8.6.3. Egypt
          8.6.4. Kuwait
          8.6.5. Saudi Arabia
          8.6.6. Rest of Middle East & Africa

9. Global Catharanthine Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in the Catharanthine market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Type Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. AK Scientific Inc
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Application Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Hainan Yueyang Biotech Co Ltd
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Application Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. Abcam
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Application Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. ChemFaces
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Application Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Stanford Chemicals
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Application Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Cayman Chemicals
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Application Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Bio Vision Inc
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Application Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Enzo Biochem Inc
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Application Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
 

List of Table

1. Global Catharanthine Market, By Type, 2022-2030 (USD Million) 

2. Global Catharanthine sulphate Catharanthine Market, By Region, 2022-2030 (USD Million) 

3. Global Catharanthine tartrate Catharanthine Market, By Region, 2022-2030 (USD Million)  

4. Global Catharanthine Market, By Application, 2022-2030 (USD Million) 

5. Global Pharmaceutical Catharanthine Market, By Region, 2022-2030 (USD Million) 

6. Global Food and Beverages Catharanthine Market, By Region, 2022-2030 (USD Million) 

7. Global Others Catharanthine Market, By Region, 2022-2030 (USD Million) 

8. Global Catharanthine Market, By Region, 2022-2030 (USD Million) 

9. Global Catharanthine Market, By North America, 2022-2030 (USD Million) 

10. North America Catharanthine Market, By Type, 2022-2030 (USD Million) 

11. North America Catharanthine Market, By Application, 2022-2030 (USD Million) 

12. U.S. Catharanthine Market, By Type, 2022-2030 (USD Million) 

13. U.S. Catharanthine Market, By Application, 2022-2030 (USD Million)  

14. Canada Catharanthine Market, By Type, 2022-2030 (USD Million) 

15. Canada Catharanthine Market, By Application, 2022-2030 (USD Million) 

16. Mexico Catharanthine Market, By Type, 2022-2030 (USD Million) 

17. Mexico Catharanthine Market, By Application, 2022-2030 (USD Million) 

18. Europe Catharanthine Market, By Type, 2022-2030 (USD Million) 

19. Europe Catharanthine Market, By Application, 2022-2030 (USD Million) 

20. Germany Catharanthine Market, By Type, 2022-2030 (USD Million) 

21. Germany Catharanthine Market, By Application, 2022-2030 (USD Million) 

22. France Catharanthine Market, By Type, 2022-2030 (USD Million) 

23. France Catharanthine Market, By Application, 2022-2030 (USD Million) 

24. U.K. Catharanthine Market, By Type, 2022-2030 (USD Million) 

25. U.K. Catharanthine Market, By Application, 2022-2030 (USD Million)  

26. Italy Catharanthine Market, By Type, 2022-2030 (USD Million) 

27. Italy Catharanthine Market, By Application, 2022-2030 (USD Million) 

28. Spain Catharanthine Market, By Type, 2022-2030 (USD Million) 

29. Spain Catharanthine Market, By Application, 2022-2030 (USD Million)

30. Rest of Europe Catharanthine Market, By Type, 2022-2030 (USD Million) 

31. Rest of Europe Catharanthine Market, By Application, 2022-2030 (USD Million)

32. Asia Pacific Catharanthine Market, By Type, 2022-2030 (USD Million) 

33. Asia Pacific Catharanthine Market, By Application, 2022-2030 (USD Million) 

34. Japan Catharanthine Market, By Type, 2022-2030 (USD Million) 

35. Japan Catharanthine Market, By Application, 2022-2030 (USD Million) 

36. China Catharanthine Market, By Type, 2022-2030 (USD Million) 

37. China Catharanthine Market, By Application, 2022-2030 (USD Million) 

38. India Catharanthine Market, By Type, 2022-2030 (USD Million) 

39. India Catharanthine Market, By Application, 2022-2030 (USD Million) 

40. Australia Catharanthine Market, By Type, 2022-2030 (USD Million) 

41. Australia Catharanthine Market, By Application, 2022-2030 (USD Million) 

42. South Korea Catharanthine Market, By Type, 2022-2030 (USD Million) 

43. South Korea Catharanthine Market, By Application, 2022-2030 (USD Million) 

44. Rest of Asia-Pacific Catharanthine Market, By Type, 2022-2030 (USD Million) 

45. Rest of Asia-Pacific Catharanthine Market, By Application, 2022-2030 (USD Million) 

46. South America Catharanthine Market, By Type, 2022-2030 (USD Million) 

47. South America Catharanthine Market, By Application, 2022-2030 (USD Million)  

48. Brazil Catharanthine Market, By Type, 2022-2030 (USD Million) 

49. Brazil Catharanthine Market, By Application, 2022-2030 (USD Million) 

50. Argentina Catharanthine Market, By Type, 2022-2030 (USD Million) 

51. Argentina Catharanthine Market, By Application, 2022-2030 (USD Million) 

52. Rest of Latin America Catharanthine Market, By Type, 2022-2030 (USD Million) 

53. Rest of Latin America Catharanthine Market, By Application, 2022-2030 (USD Million) 

54. Middle East and Africa Catharanthine Market, By Type, 2022-2030 (USD Million) 

55. Middle East and Africa Catharanthine Market, By Application, 2022-2030 (USD Million) 

56. UAE Catharanthine Market, By Type, 2022-2030 (USD Million) 

57. UAE Catharanthine Market, By Application, 2022-2030 (USD Million) 

58. South Africa Catharanthine Market, By Type, 2022-2030 (USD Million) 

59. South Africa Catharanthine Market, By Application, 2022-2030 (USD Million) 

60. Egypt Catharanthine Market, By Type, 2022-2030 (USD Million) 

61. Egypt Catharanthine Market, By Application, 2022-2030 (USD Million) 

62. Kuwait Catharanthine Market, By Type, 2022-2030 (USD Million) 

63. Kuwait Catharanthine Market, By Application, 2022-2030 (USD Million) 

64. Saudi Arabia Catharanthine Market, By Type, 2022-2030 (USD Million) 

65. Saudi Arabia Catharanthine Market, By Application, 2022-2030 (USD Million) 

66. Rest of Middle East Catharanthine Market, By Type, 2022-2030 (USD Million) 

67. Rest of Middle East Catharanthine Market, By Application, 2022-2030 (USD Million) 

List of Figures 

1. Global Catharanthine Market Segmentation

2. Catharanthine Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Catharanthine Market Attractiveness Analysis By Type

9. Global Catharanthine Market Attractiveness Analysis By Application

10. Global Catharanthine Market Attractiveness Analysis By Region

11. Global Catharanthine Market: Dynamics

12. Global Catharanthine Market Share By Type (2022 & 2030)

13. Global Catharanthine Market Share By Application (2022 & 2030)

14. Global Catharanthine Market Share by Regions  (2022 & 2030)

15. Global Catharanthine Market Share by Company  (2021)

By Type

  • Catharanthine sulphate
  • Catharanthine tartrate

By Application

  • Pharmaceutical
  • Food and Beverages
  • Others

By Region/Geography

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
  • Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date